Neoadjuvant Nivolumab Aids In Long Term Lung Cancer Survival
Final assessments of a Phase II trial for resectable non-small cell lung cancer found that 60% of patients who had gone on to receive...
CMS Tests Three New Ways To Bring Down The Cost of Drugs
It has come to light that the federal health agencies have gone on to select three new models so as to lower the prices...
Clinical Trials Diversity – A Much To Be Explored Segment
Biopharma companies as well as policymakers know the significance of assessing medical and drug products across a broad range of racial and ethnic universes...
HPAPI Market Witnesses A Surge Globally With A CAGR of 8.6%
As per a market report by Reportlinker, the worldwide highly potent active pharmaceutical ingredient- HPAPI sector is anticipated to breach the $34.04 billion mark...
Cancer Vaccine Transformation – A Possibility Soon To Occur
Researchers at Northwestern University's International Institute for Nanotechnology (IIN) have devised a novel method for dramatically increasing the potency of practically any vaccine. The...
4 Pharma Supply Chain Factors That Need To Be Focussed Upon
The post-pandemic future of healthcare has compelled one to re-evaluate the supply chain from end-to-end.
Be it new technologies, shortened clinical trials, next-gen medical innovations,...
3 Innovative Elements Shaping Life Sciences Spectrum In 2023
In 2023, there are going to be numerous factors that will influence the life science sector, in turn forcing leaders to re-evaluate existing practises...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...